← All organizations

Cerevance

For profit

Also known as: Cerevance | Cerevance Beta, Inc. | Cerevance, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Sep 20, 2024

Timeline

2010s

Jul 1, 2016
Cerevance— Founded

Drugs by trial phase (3 distinct, 7 trials)

Phase 3 (1 own, 0 via acquisition)

cvn424

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (11)

NCT06553027Lead sponsorPhase 3Sep 20, 2024
NCT06006247Lead sponsorPhase 2Sep 11, 2023
NCT05635461Lead sponsorPhase 1Oct 9, 2022
NCT05635461Study chairPhase 1Oct 9, 2022
NCT05105243Lead sponsorPhase 1Jan 31, 2022
NCT04191577Lead sponsorPhase 2Dec 2, 2019
NCT04191577Study chairPhase 2Dec 2, 2019
NCT03669250Study chairPhase 1Sep 30, 2018
NCT03669250Lead sponsorPhase 1Sep 30, 2018
NCT03657030Lead sponsorPhase 1Aug 31, 2018
NCT03657030Study directorPhase 1Aug 31, 2018

Details

Founded: Cambridge, MA, US Jul 1, 2016
Last known activity: Sep 20, 2024